Antiobesity Effect of Allenic Carotenoid, Fucoxanthin

Nutrigenomics and Proteomics in Health and Disease: Food Factors and Gene Interactions

Volumn , Issue , 2009, Pages 145-160

  Miyashita, Kazuo ^a   Hosokawa, Masashi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

adaptive thermogenesis in brown adipose tissue (BAT); Allenic carotenoids; Allenic carotenoids on lipid accumulation in adipose cells; Antidiabetic effect of fucoxanthin; Antiobesity effect of allenic carotenoid, fucoxanthin; Best known biological function of carotenoids established role as provitamin A; Fucoxanthin antiobesity effect; Inhibitory effect of allenic carotenoids on cancer cells; Seaweed carotenoid, fucoxanthin and health beneficial effects; UCP1 important molecular target for antiobesity

Indexed keywords

EID: 72049129897     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780813807263.ch11     Document Type: Chapter

References (105)

1. Ailhaud G, Grimaldi P and Négrel R. 1992. Cellular and molecular aspects of adipose tissue development. Annu Rev Nutr. 12:207-233.
2. Argyropoulos G and Harper M-E. 2002. Molecular biology of thermoregulation. Invited review: Uncoupling proteins and thermoregulation. J Appl Physiol. 92(5):2187-2198.
3. Arsenijevic D, Onuma H, Pecqueur C, Raimbault S, Manning BS, Miroux B, Couplan E, Alves-Guerra M-C, Goubern M, Surwit R, Bouillaud F, Richard D, Collins S, and Ricquier D. 2000. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genetics. 26(4):435-439.
4. Asai A, Sugawara T, Ono H, and Nagao A. 2004. Biotransformation of fucoxanthinol into amarouciaxanthin A in mice and HepG2 cells: Formation and cytotoxicity of fucoxanthin metabolites. Drug Metab Dispos. 32(2):205-211.
5. Astley SB, Hughes DA, Wright AJA, Elliott RM, and Southon S. 2004. DNA damage and susceptibility to oxidative damage in lymphocytes: Effects of carotenoids in vitro and in vivo. Br J Nutr. 91(1):53-61.
6. Basu HN, Del Vecchio AJ, Flider F, and Orthoefer FT. 2001. Nutritional and potential disease prevention properties of carotenoids. J Am Oil Chem Soc. 78(7):665-675.
7. Bertram JS and Vine AL. 2005. Cancer prevention by retinoids and carotenoids: Independent action on a common target. Biochim Biophys Acta. 1740(2):170-178.
8. Britton G. 1995. Structure and properties of carotenoids in relation to function. FASEB J. 9(15):1551-1558.
9. Cederberg A, Grønning LM, Ahrén B, Taskén K, Carlsson P, and Enerbäck S. 2001. FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell. 106(5):563-573.
10. Che Man YB and Manaf MA. 2006. Medium-chain triacylglycerols. In: Shahidi F (Ed), Nutraceuticals and Specialty Lipids and Their Co-Products, CRC Press, Boca Raton, FL, pp 27-56.
11. Che Man YB and Tan C-P. 2003. Carotenoids. In: Gunstone FD (Ed), Lipids for Functional Foods and Nutraceuticals, The Oily Press, New York, pp 25-53.
12. Chew BP and Park JS. 2004. Carotenoid action on the immune response. J Nutr. 134(1):257S-261S.
13. Collins AR. 2001. Carotenoids and genomic stability. Mutat Res. 475(1-2):21-28.
14. Collins S, Daniel KW, Petro AE, and Surwit RS. 1997. Strain-specific response to ß3-adrenergic receptor agonist treatment of diet-induced obesity in mice. Endocrinology. 138(1):405-413.
15. Cooper DA, Eldridge AL, and Peters JC. 1999a. Dietary carotenoids and lung cancer: A review of recent research. Nutr Rev. 57(5):133-145.
16. Cooper DA, Eldridge AL, and Peters JC. 1999b. Dietary carotenoids and certain cancers, heart disease and age related macular degeneration: A review of recent research. Nutr Rev. 57(7):201-214.
17. Cousin B, Bascands-Viguerie N, Kassis N, Nibbelink M, Ambid L, Casteilla L, and Pénicaud L. 1996. Cellular changes during cold acclimatation in adipose tissues. J Cell Physiol. 167(2):285-289.
18. Czeczuga B and Taylor FJ. 1987. Carotenoid content in some species of the brown and red algae from the coastal area of New Zealand. Biochem Syst Ecol. 15(1):5-8.
19. Dalgaard LT and Pedersen O. 2001. Uncoupling proteins: Functional characteristics and role in the pathogenesis of obesity and type II diabetes. Diabetologia. 44(8):946-965.
20. WAF1/Cip1. Biochim Biophys Acta. 1726(3):328-335.
21. De Luca LM. 1991. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J. 5(14):2924-2933.
22. Del Mar Gonzalez-Barroso M, Ricquier D, and Cassard-Doulcier A-M. 2000. The human uncoupling protein-1 gene (UCP1): Present status and perspectives in obesity research. Obesity Rev. 1(2):61-72.
23. Dembitsky VM and Maoka T. 2007. Allenic and cumulenic lipids. Prog Lipid Res. 46(6):328-375.
24. Dulloo AG, Duret C, Rohrer D, Girardier L, Mensi N, Fathi M, Chantre P, and Vandermander J. 1999. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr. 70(6):1040-1045.
25. Dulloo AG and Samec S. 2001. Uncoupling proteins: Their roles in adaptive thermogenesis and substrate metabolism reconsidered. British J Nutr. 86(2):123-139.
26. Edge R, McGarvey DJ, and Truscott TG. 1997. The carotenoids as anti-oxidants-A review. J Photochem Photobiol B. 41(3):189-200.
27. Elberg G, Gimble JM, and Tsai SY. 2000. Modulation of the murine peroxisome proliferator-activated receptor γ2 promoter activity by CCAAT/enhancer-binding proteins. J Biol Chem. 275(36):27815-27822.
28. Evans P and Halliwell B. 2001. Micronutrients: Oxidant/antioxidant status. Br J Nutr. 85(Suppl. 2):S67-S74.
29. Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyrueis C, Bouillaud F, Seldin MF, Surwit RS, Ricquier D, and Warden CH. 1997. Uncoupling protein-2: A novel gene linked to obesity and hyperinsulinemia. Nat Genetics. 15(3):269-272.
30. Flickinger BD. 2006. Diacyglycerols (DAGs) and their mode of action. In: Shahidi F (Ed), Nutraceuticals and Specialty Lipids and Their Co-Products, CRC Press, Boca Raton, Florida, pp 181-186.
31. Flickinger BD and Matsuo N. 2003. Nutritional characteristics of DAG oil. Lipids. 38(2):129-1323.
32. Frederich RC, Hamann A, Anderson S, Löllmann B, Lowell BB, and Flier JS. 1995. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nat Med. 1(12):1311-1314.
33. Frühbeck G, Gómez-Ambrosi J, Muruzábal FJ, and Burrell MA. 2001. The adipocyte: A model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab. 280(6):827-847.
34. Gerster H. 1997. The potential role of lycopene for human health. J Am Coll Nutr. 16(2):109-126.
35. Ghorbani M and Himms-Hagen J. 1997. Appearance of brown adipocytes in white adipose tissue during CL 316,243-induced reversal of obesity and diabetes in Zucker fa/fa rats. Int J Obes. 21(6):465-475.
36. Giovannucci E. 1999. Tomatoes, tomato-based products, lycopene, and cancer: Review of the epidemiologic literature. J Natl Cancer Inst. 91(4):317-331.
37. Gong D-W, Monemdjou S, Garvilova O, Leon LR, Marcus-Samuels B, Chou CJ, Everett C, Kozak LP, Li C, Deng C, Harper M-E, and Reitman ML. 2000. Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3. J Biol Chem. 275(21):16251-16257.
38. Gregoire FM. 2001. Adipocyte differentiation: From fibroblast to endocrine cell. Exp Biol Med. 226(11):997-1002.
39. Gregoire FM, Smas CM, and Sul HS. 1998. Understanding adipocyte differentiation. Physiol Rev. 78(3):783-809.
40. Grimaldi PA. 2001. The roles of PPARs in adipocyte differentiation. Prog Lipid Res. 40(4):269-281.
41. Guerra C, Koza RA, Yamashita H,Walsh K, and Kozak LP. 1998. Emergence of brown adipocytes in white fat in mice is under genetic control: Effects on body weight and adiposity. J Clin Invest. 102(2):412-420.
42. Hadley CW, Miller EC, Schwartz SJ, and Clinton SK. 2002. Tomatoes, lycopene, and prostate cancer: Progress and promise. Exp Biol Med. 227(10):869-880.
43. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, and Friedman JM. 1995. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269(5223):543-546.
44. Halliwell B. 1996. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Rad Res. 25(1):57-74.
45. Harper M-E, Dent RM, Bezaire V, Antoniou A, Gauthier A, Monemdjou S, and McPherson R. 2001. UCP3 and its putative function: Consistencies and controversies. Biochem Soc Trans. 29(6):768-773.
46. Hosokawa M, Kudo M, Maeda H, Kohno H, Tanaka T, and Miyashita K. 2004. Fucoxanthin induces apoptosis and enhances the antiproliferative effect of the PPARγ ligand, troglitazone, on colon cancer cells. Biochim Biophys Acta. 1675(1-3):113-119.
47. Hosokawa M, Wanezaki S, Miyauchi K, Kurihara H, Kohno H, Kawabata J, Odashima S, and Takahashi K. 1999. Apoptosis inducing effect of fucoxanthin on human leukemia cell line HL-60. Food Sci Technol Res. 5(3):243-246.
48. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, and Spiegelman BM. 1995. Increased adipose tissue expression of tumor necrosis factor-a in human obesity and insulin resistance. J Clin Invest. 95(5):2409-2415.
49. Hotamisligil GS, Shargill NS, and Spiegelman BM. 1993. Adipose expression of tumor necrosis factor-a: Direct role in obesity-linked insulin resistance. Science. 259(5091):87-91.
50. Jackson MJ, Papa S, Bolaños J, Bruckdorfer R, Carlsen H, Elliott RM, Flier J, Griffiths HR, Heales S, Holst B, Lorusso M, Lund E, Øivind Moskaug J, Moser U, Di Paola M, Polidori MC, Signorile A, Stahl W, Viña-Ribes J, and Astley SB. 2002. Antioxidants, reactive oxygen and nitrogen species, gene induction and mitochondrial function. Mol Aspects Med. 23(1-3):209-285.
51. Ježek P. 2002. Possible physiological roles of mitochondrial uncoupling proteins-UCPn. Inter J Biochem Cell Biol. 34(10):1190-1206.
52. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, and Tobe K. 2006. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 116(7):1784-1792.
53. Kawada T, Hagihara K, and Iwai K. 1986. Effects of capsaicin on lipid metabolism in rats fed a high fat diet. J Nutr. 116(7):1272-1278.
54. Kawada T, Sakabe S, Aoki N, Watanabe T, Higeta K, Iwai K, and Sugimoto E. 1991. Intake of sweeteners and pungent ingredients increases the thermogenin content in brown adipose tissue of rat. J Agric Food Chem. 39(4):651-654.
55. Klaus S, Pültz S, Thöne-reineke C, and Wolfram S. 2005. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obesity. 29(6):615-623.
56. Kopecký J, Baudyšová M, Zanotti F, Janiková D, Pavelka S, and Houštek J. 1990. Synthesis of mitochondrial uncoupling protein in brown adipocytes differentiated in cell culture. J Biol Chem. 265(36):22204-22209.
57. Kopelman PG. 2000. Obesity as a medical problem. Nature. 404(6778):635-643.
58. Kotake-Nara E, Kushiro M, Zhang H, Sugawara T, Miyashita K, and Nagao A. 2001. Carotenoids affect proliferation of human prostate cancer cells. J Nutr. 131(12):3303-3306.
59. Kotake-Nara E, Terasaki M, and Nagao A. 2005. Characterization of apoptosis induced by fucoxanthin in human promyelocytic leukemia cells. Biosci Biotechnol Biochem. 69(1):224-227.
60. Kovacs EMR and Mela DJ. 2006. Metabolically active functional foods for weight control. Obes Rev. 7(1):59-78.
61. Lane MD, Tang Q-Q, and Jiang M-S. 1999. Role of the CCAAT enhancer binding proteins (C/EBPs) in adipocyte differentiation. Biochem Biophys Res Commun. 266(3):677-683.
62. Lee SM and Bressler R. 1981. Prevention of diabetic nephropathy by diet control in the db/db mouse. Diabetes. 30(2):106-111.
63. Loncar D. 1991. Convertible adipose tissue in mice. Cell Tissue Res. 266(1):149-161.
64. Lowell BB and Spiegelman BM. 2000. Towards a molecular understanding of adaptive thermogenesis. Nature. 404(6778):652-660.
65. Maeda H, Hosokawa M, Sashima T, Funayama K, and Miyashita K. 2005. Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues. Biochim Biophys Res Commun. 332(2):392-397.
66. Maeda H, Hosokawa M, Sashima T, Funayama K, and Miyashita K. 2007a. Effect of medium-chain triacylglycerols on anti-obesity effect of fucoxanthin. J Oleo Sci. 56(12):615-621.
67. Maeda H, Hosokawa M, Sashima T, and Miyashita K. 2007b. Dietary combination of fucoxanthin and fish oil attenuates the weight gain of white adipose tissue and decreases blood glucose in obese/diabetic KK-Ay mice. J Agric Food Chem. 55(19):7701-7706.
68. Maeda H, Hosokawa M, Sashima T, Takahashi N, Kawada T, and Miyashita K. 2006. Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells. Int J Mole Med. 18(1):147-152.
69. Masuda Y, Haramizu S, Oki K, Ohnuki K,Watanabe T, Yazawa S, Kawada T, Hashizume S, and Fushiki T. 2003. Upregulation of uncoupling proteins by oral administration of capsiate, a nonpungent capsaicin analog. J Appl Phys. 95(6):2408-2415.
70. Masuzaki H, Ogawa Y, Aizawa-Abe M, Hosoda K, Suga J, Ebihara K, Satoh N, Iwai H, Inoue G, Nishimura H, Yoshimasa Y, and Nakao K. 1999. Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: Usefulness of leptin for the treatment of obesity-associated diabetes. Diabetes. 48(8):1615-1622.
71. Matsuno T. 2001. Aquatic animal carotenoids. Fisheries Sci. 67(5):771-783.
72. Matsuzawa Y. 2006. The metabolic syndrome and adipocytokines. FEBS Lett. 580(12):2917-2921.
73. Molnár J, Gyémánt N, Tanaka M, Hohmann J, Bergmann-Leitner E, Molnár P, Deli J, Didiziapetris R, and José Umbelino Ferreira M. 2006. Inhibition of multidrug resistance of cancer cells by natural diterpenes, triterpenes and carotenoids. Curr Pharm Design. 12(3):287-311.
74. Mozo J, Emre Y, Bouillaud F, Ricquier D, and Criscuolo F. 2005. Thermoregulation: What role for UCPs in mammals and birds?. Biosci Reports. 25(3-4):227-249.
75. Nagase I, Yoshida T, Kumamoto K, Umekawa T, Sakane N, Nikami H, Kawada T, and Saito M. 1996. Expression of uncoupling protein in skeletal muscle and white fat of obese mice treated with thermogenic ß3-adrenergic agonist. J Clin Invest. 97(12):2898-2904.
76. Nedergaard J, Golozoubova V, Matthias A, Asadi A, Jacobsson A, and Cannon B. 2001. UCP1: The only protein able to mediate adaptive non-shivering thermogenesis and metabolic inefficiency. Biochim Biophys Acta. 1504(1):82-106.
77. Okada T, Nakai M, Maeda H, Hosokawa M, Sashima T, and Miyashita K. 2008. A comparative study on the ability of carotenoids to suppress differentiation of 3T3-L1 cells. J Oleo Sci. 57(6):345-151.
78. Palozza P, Serini S, Di Nicuolo F, and Calviello G. 2004. Modulation of apoptotic signalling by carotenoids in cancer cells. Arch Biochem Biophys. 430(1):104-109.
79. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, and Collins F. 1995. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 269(5223):540-543.
80. Porrini M and Riso P. 2000. Lymphocyte lycopene concentration and DNA protection from oxidative damage is increased in women after a short period of tomato consumption. J Nutr. 130(2):189-192.
81. Rao AV and Rao LG. 2007. Carotenoids and human health. Pharmacol Res. 55(3):207-216.
82. Rehnmark S, Néchad M, Herron D, Cannon B, and Nedergaard J. 1990. α-and ß-Adrenergic induction of the expression of the uncoupling protein thermogenin in brown adipocytes differentiated in culture. J Biol Chem. 265(27):16464-16471.
83. Riboli E and Norat T. 2003. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Cli Nutr. 78(3):559S-569S.
84. Rosen ED, Hsu C-H, Wang X, Sakai S, Freeman MW, Gonzalez FJ, and Spiegelman BM. 2002. C/EBPα induces adipogenesis through PPARγ: A unified pathway. Genes Dev. 16(1):22-26.
85. Rosen ED, Walkey CJ, Puigserver P, and Spiegelman BM. 2000. Transcriptional regulation of adipogenesis. Genes Dev. 14(11):1293-1307.
86. Rothwell NJ and Stock MJ. 1979. A role for brown adipose tissue in diet-induced thermogenesis. Nature. 281(5726):31-35.
87. Rühl R. 2007. Effects of dietary retinoids and carotenoids on immune development. Proc Nutr Soc. 66(3):458-469.
88. Seddon JM. 2007. Multivitamin-multimineral supplements and eye disease: Age-related macular degeneration and cataract. Am J Clin Nutr. 85(1):304S-307S.
89. Sharoni Y, Agbaria R, Amir H, Ben-Dor A, Bobilev I, Doubi N, Giat Y, Hirsh K, Izumchenko G, Khanin M, Kirilov E, Krimer R, Nahum A, Steiner M, Walfisch Y, Walfisch S, Zango G, Danilenko M, and Levy J. 2003. Modulation of transcriptional activity by antioxidant carotenoids. Mol Aspects Med. 24(6):371-384.
90. Silva JE and Rabelo R. 1997. Regulation of the uncoupling protein gene expression. Eur J Endocrinol. 136(3):251-264.
91. Smith RE and Horwitz BA. 2005. Brown fat and thermogenesis. Physiol Rev. 49(2):330-425.
92. Soloveva V, Graves RA, Rasenick MM, Spiegelman BM, and Ross SR. 1997. Transgenic mice overexpressing the ß1-adrenergic receptor in adipose tissue are resistant to obesity. Mol Endocrinol. 11(1):27-38.
93. Spiegelman BM and Flier JS. 1996. Adipogenesis and obesity: Rounding out the big picture. Cell. 87(3):377-389.
94. St-Onge MP. 2005. Dietary fats, teas, dairy, and nuts: Potential functional foods for weight control?. Am J Clin Nutr. 81(1):7-15.
95. Sugawara T, Baskaran V, Tsuzuki W, and Nagao A. 2002. Brown algae fucoxanthin is hydrolyzed to fucoxanthinol during absorption by Caco-2 human intestinal cells and mice. J Nutr. 132(5):946-951.
96. Tapiero H, Townsend DM, and Tew KD. 2004. The role of carotenoids in the prevention of human pathologies. Biomed Pharmacotherapy. 58(2):100-110.
97. Tontonoz P, Hu E, and Spiegelman BM. 1994. Stimulation of adipogenesis in fibroblasts by PPARγ 2, a lipid-activated transcription factor. Cell. 79(7):1147-1156.
98. Tsukui T, Konno K, Hosokawa M, Maeda H, Sashima T, and Miyashita K. 2007. Fucoxanthin and fucoxanthinol enhance the amount of docosahexaenoic acid in the liver of KKAy obese/diabetic mice. J Agric Food Chem. 55(13):5025-5029.
99. Vidal-Puig AJ, Grujic D, Zhang C-Y, Hagen T, Boss O, Ido Y, Szczepanik A, Wade J, Mootha V, Cortright R, Muoio DM, and Lowell BB. 2000. Energy metabolism in uncoupling protein 3 gene knockout mice. J Biol Chem. 275(21):16258-16266.
100. Visscher TL. 2001. The public health impact of obesity. Annu Rev Public Health. 22:355-375.
101. Willett WC. 2001. Diet and cancer: One view at the start of the millennium. Cancer Epidemiol Biomark Prev. 10(1):3-8.
102. Wong KH and Cheung PCK. 2000. Nutritional evaluation of some subtropical red and green seaweeds. Part-I, proximate composition, amino acid profiles and some physico-chemical properties. Food Chem. 71(4):475-482.
103. Wu Z, Bucher NL, and Farmer SR. 1996. Induction of peroxisome proliferator-activated receptor γ during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPß, C/EBPδ, and glucocorticoids. Mol Cell Biol. 16(8):4128-4136.
104. Wu Z, Rosen ED, Brun R, Hauser S, Adelmant G, Troy AE, McKeon C, Darlington GJ, and Spiegelman BM. 1999. Cross-regulation of C/EBPα and PPARγ controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell. 3(2):151-158.
105. Young P, Arch JRS, and Ashwell M. 1984. Brown adipose tissue in the parametrial fat pad of the mouse. FEBS Lett. 167(1):10-14.